文献速递临床微生物质量管理与危急值

快速抗菌药物敏感性试验对革兰阴性杆菌菌血症的影响:一项准实验研究

Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study.
PubMed 文献 · J Clin Microbiol · 2020-08-24

该研究在2018年2月至2019年7月于一家三级医院开展前后对照准实验,评估基于阳性血培养肉汤直接Vitek 2快速AST联合电子降阶梯注释和日间抗菌药物管理干预对GNR菌血症的影响。共纳入643例成人患者的671株GNR分离株,快速AST组在结果报告后调整抗生素的患者中至升级或降阶梯时间呈减少趋势(HR 1.22,95%CI 0.99-1.51,P=0.06),中位时间52.3 vs 42.2小时,但口服降阶梯时间、住院时长、30天全因死亡率、7天AKI发生率和30天CDI发生率均相似。快速AST改善了抗菌药物管理指标但未影响临床结局。

要点

  • 快速AST联合ASP干预使抗生素调整时间呈减少趋势但未达统计学显著。
  • 快速AST未显著改善住院时长、死亡率、AKI或CDI等临床结局。
  • 除AST报告时机外,多种因素共同影响临床结局。

核心结论

  • 快速AST改善了抗菌药物管理措施但未影响临床患者结局。
  • 除AST报告时机外,多种变量共同影响临床结局,可能需要进一步干预以在临床层面论证快速AST实施的价值。

研究设计与样本

  • 前后对照准实验研究,2018年2月至2019年7月在一家三级医院开展。
  • 干预为每日24小时、每周7天对阳性血培养肉汤直接Vitek 2快速AST,联合电子分离株特异性降阶梯注释和日间抗菌药物管理项目(ASP)干预。
  • 共纳入643例成人患者的671株革兰阴性杆菌(GNR)分离株。

主要发现

  • 在快速AST结果后发生抗生素调整的患者中,快速AST与至升级或降阶梯时间减少的趋势相关(风险比1.22;95%CI 0.99-1.51;P=0.06),中位时间52.3 vs 42.2小时。
  • 两组口服抗生素降阶梯中位时间、住院时长、全因30天死亡率、7天急性肾损伤(AKI)发生率和30天艰难梭菌感染(CDI)发生率相似。

临床怎么用

  • 快速AST可改善抗菌药物管理指标,但临床结局的改善可能需要结合其他干预措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical justification for rapid antimicrobial susceptibility testing (AST) in Gram-negative rod (GNR) bacteremia is compelling; however, evidence supporting its value is sparse. We investigated the impact of rapid AST on clinical and antimicrobial stewardship outcomes in real-world practice. We performed a before-and-after quasi-experimental study from February 2018 to July 2019 at a tertiary hospital of the 24-h/day, 7-day/week implementation of the direct Vitek 2 AST method from positive blood culture broth for GNR bacteremia with electronic isolate-specific de-escalation comments and daytime antibiotic stewardship program (ASP) intervention. The primary outcome was time to appropriate antibiotic escalation or de-escalation, and secondary outcomes included time to oral antibiotic stepdown, hospital length of stay (LOS), all-cause 30-day mortality, 7-day incidence of acute kidney injury (AKI), and 30-day incidence of Clostridioides difficile infection (CDI). A total of 671 GNR isolates were included from 643 adult patients. Among patients for whom antibiotic change occurred after rapid AST result, rapid AST was associated with a trend in decreased time to escalation or de-escalation (hazard ratio, 1.22; 95% confidence interval [CI], 0.99 to 1.51; P = 0.06), with median times of 52.3 versus 42.2 h. Secondary outcomes were similar in both groups and include median time to oral antibiotic stepdown, LOS, all-cause mortality, and incidence of AKI and CDI. Rapid AST led to improved stewardship measures but did not impact clinical patient outcomes. These results highlight that multiple variables in addition to the timing of the AST result contribute to clinical outcome and that further intervention may be required to clinically justify rapid AST implementation.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Hogan CA, Ebunji B, Watz N, et al. Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study. J Clin Microbiol. 2020. PMID: 32434782. doi:10.1128/JCM.00360-20

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。